Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/01/2003US20030080314 Method and device for taking measurements of cells which are contained in a liquid environment
05/01/2003US20030080160 Liquid droplet ejecting method and a liquid droplet ejection apparatus
05/01/2003US20030080063 High-sensitivity method and apparatus for monitoring impurities in water
05/01/2003US20030080062 Methods and apparatus for characterization of polymers using multi-dimensional liquid chromatography with regular second-dimension sampling
05/01/2003US20030080002 Method and apparatus for detection of a bubble in a liquid
05/01/2003US20030080001 Heating the sample in a disposable test cell; and measuring the concentration of the analyte or a concentration of a species representative of the analyte in the sample at a predetermined point on a reaction profile
05/01/2003US20030079999 For measuring the concentration of hydrogen in a flowing gas stream
05/01/2003US20030079987 Heated electrochemical cell
05/01/2003US20030079556 System and method for testing a multilayer preform
05/01/2003US20030079544 Method of evaluating logs to predict warp propensity of lumber sawn from the logs
05/01/2003CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2470197A1 Mycobacterial genes down-regulated during latency
05/01/2003CA2468125A1 Target specific screening and its use for identifying target binders
05/01/2003CA2465288A1 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003CA2465274A1 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample
05/01/2003CA2465261A1 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
05/01/2003CA2465099A1 Separation device, analysis system, separation method, and method of manufacturing the separation device
05/01/2003CA2464700A1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
05/01/2003CA2464682A1 Method and apparatus for high-throughput sample handling process line
05/01/2003CA2464476A1 Optical biological disk analyser
05/01/2003CA2464469A1 Identification of material inclusions in pulp and paper using raman spectroscopy
05/01/2003CA2464467A1 Method and apparatus for parallel dispensing of defined volumes of solid particles
05/01/2003CA2464466A1 Method and apparatus for distinguishing crohn's disease from ulcerative colitis by detecting fecal antibodies to saccharomyces cerevisiae
05/01/2003CA2464460A1 In vitro micro-organs, and uses related thereto
05/01/2003CA2464396A1 Method for screening agent acting on cell wall
05/01/2003CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
05/01/2003CA2464277A1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment
05/01/2003CA2464239A1 Psma antibodies and protein multimers
05/01/2003CA2464088A1 Stem cells that transform to beating cardiomyocytes
05/01/2003CA2463946A1 Assay for phospholipid transfer protein (pltp) activity
05/01/2003CA2463746A1 Methods and compositions to evaluate antibody treatment response
05/01/2003CA2463467A1 Cell separation matrix
05/01/2003CA2463420A1 Methods for detecting genetic haplotypes by interaction with probes
05/01/2003CA2462937A1 Analysis of temperature-dependent molecular configurations
05/01/2003CA2462581A1 Diagnostic method
05/01/2003CA2462238A1 Specimen vial sealing apparatus and method
05/01/2003CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2461543A1 Sperm factor sequences
05/01/2003CA2461182A1 Use of tyrosine kinase inhibitors for promoting hair growth
05/01/2003CA2461181A1 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections
05/01/2003CA2461162A1 On-line determination of wax crystallization temperature of waxy solvent stream
05/01/2003CA2460944A1 Lrrcaps as modifiers of the p53 pathway and methods of use
05/01/2003CA2458802A1 Rapid and sensitive detection of molecules
05/01/2003CA2429505A1 Prevention of recurrent viral disease
05/01/2003CA2402588A1 Taxonomic identification of pathogenic microorganisms and their toxic proteins
04/2003
04/30/2003CN2548160Y Foreign matter detecting apparatus for medicinal powder or injection bottle
04/30/2003CN2548141Y Moveable concrete, mortar sampler cultivation room
04/30/2003CN1415074A Method of detection of amyloidogenic proteins
04/30/2003CN1415073A Bases for fixed ligands
04/30/2003CN1415013A BASB059 polypeptides from neisseria meningitidis
04/30/2003CN1414951A Drug discharge pump inhibitors
04/30/2003CN1414871A Placental human necerokinin B precursor
04/30/2003CN1414865A 癌症的治疗 Treatment of cancer
04/30/2003CN1414392A Separable photoelectric liquid drop sensor
04/30/2003CN1414390A Fipronil immune detecting method
04/30/2003CN1414389A HCV and TORCH protein chip and its preparation and application method
04/30/2003CN1414388A Dynamic temperature change detecting method of biochip and chip detecting equipment
04/30/2003CN1414387A Oxygen sensitive paramagnetic biomedicine sensor material
04/30/2003CN1414386A New qualitative and/or quantitative determination method
04/30/2003CN1414380A Constant volume sampling flameless combustion type fuel gas caloric value determination apparatus
04/30/2003CN1414370A Method for investigating fresh degree of rice grains
04/30/2003CN1414367A Lever type fixed load material testing machine
04/30/2003CN1414363A Bioactive target and method for medicine screening and protein structure research
04/30/2003CN1414116A Detecting and analyzing method of unburned coal powder content in blast furnace dust
04/30/2003CN1414100A Desmocyte growth factor 13
04/30/2003CN1414021A Desmocyte growth factor 13 antibody, antagonist and agonist
04/30/2003CN1414020A Desmocyte growth factor 11 antibody, antagonist and agonist
04/30/2003CN1414017A Preparation of anti cytoplasmic thymidine kinase-IgY and tumor diagnosis composition
04/30/2003CN1107230C Method of determining degree of aggregation of beta A4 peptide
04/30/2003CN1107229C Test piece for measuring magnesium in biological fluid
04/30/2003CN1107228C Method for producing blood separating agent
04/30/2003CN1107227C Instrument for analyzing water content in oil
04/30/2003CN1107115C System for expression of heterologous antigens as fusion proteins
04/30/2003CA2410134A1 Serological assay for neospora caninum
04/29/2003US6556930 Fluid treatment apparatus
04/29/2003US6556853 Spectral bio-imaging of the eye
04/29/2003US6555582 Eye treatments using synthetic thyroid hormone compositions
04/29/2003US6555392 Antisera tray
04/29/2003US6555391 Methods of conditioning an affinity resin after storage
04/29/2003US6555390 Chromatographic assay or test device
04/29/2003US6555388 A sequential assay using an endogenous intrinsic factor and antibinding-protein antibodies to measure quantitatively Vitamin B12 and folate in serum or plasma
04/29/2003US6555385 Sampling bottle for chlorinated organic compounds
04/29/2003US6555384 Microscope slide or a diagnostic plate that has a border applied by a pen to contain a biological sample
04/29/2003US6555382 Solution for fast visualization of protein
04/29/2003US6555381 Mixing blood various amounts of activating factors, anticoagulants and platelet inhibitors; measuring clotting times
04/29/2003US6555379 Device for monitoring a processing liquid
04/29/2003US6555377 Process for production of mammalian cell lines
04/29/2003US6555362 Dna bound to carbon nanotubes
04/29/2003US6555358 Chemotherapeutic target for antiprotozoal agents
04/29/2003US6555352 Peptide for use in human therapeutics and diagnostic compositions
04/29/2003US6555341 Gamma-aminobutyric acid (GABA); stably co-transfected eukaryotic cell line capable of expressing a human GABAa receptor which comprises a theta receptor subunit and at least one receptor subunit; drug screening
04/29/2003US6555339 Altering human G protein-coupled receptors (GPCRs) by point mutation; use in drug screening
04/29/2003US6555330 Oncogene-induced apoptosis in drug-resistant cells
04/29/2003US6555329 Detecting a modulator of chromosomal stability during meiosis amd mitosis; obtain cell sample, incubate with modulator and substrate, monitor cell for adjustment in cell division
04/29/2003US6555328 Drug screening for compounds that alter phosphorylation of one or more human Period proteins
04/29/2003US6555327 Monoclonal antibodies against S100
04/29/2003US6555326 Screening for drugs effecting nuclear hormone receptor function which includes the use a a peptide sensor covalently attached to a fluorescent dye in the absence of a natural coactivator protein of said receptor
04/29/2003US6555325 Kit for screening of test compounds that modulate a heterologous G protein-coupled receptor in a yeast cell uses a mixture of yeast cells; modulators of heterologous receptors coupled to the pheromone response pathway in yeast
04/29/2003US6555324 By means of flow cytometry, wherein said cells are labelled with fluorescently labelled monoclonal antibodies
1 ... 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 ... 3937